25 years of biologic DMARDs in rheumatology

Affiliations

¹ Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. marc.feldmann@kennedy.ox.ac.uk.
² Imperial College London, London, UK. ravinder@rnmaini.co.uk.
³ Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and Instituto Universitario, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. enrique.soriano@hospitalitaliano.org.ar.
⁴ Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA. vstrand@stanford.edu.
⁵ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. tsutake@z5.keio.jp.
⁶ Saitama Medical School, Saitama, Japan. tsutake@z5.keio.jp.

Marc Feldmann et al. Nat Rev Rheumatol. 2023 Dec.

. 2023 Dec;19(12):761-766.

doi: 10.1038/s41584-023-01036-x. Epub 2023 Nov 2.

¹ Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. marc.feldmann@kennedy.ox.ac.uk.
² Imperial College London, London, UK. ravinder@rnmaini.co.uk.
³ Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and Instituto Universitario, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. enrique.soriano@hospitalitaliano.org.ar.
⁴ Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA. vstrand@stanford.edu.
⁵ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. tsutake@z5.keio.jp.
⁶ Saitama Medical School, Saitama, Japan. tsutake@z5.keio.jp.

No abstract available

References

1. Brennan, F. M., Chantry, D., Jackson, A., Maini, R. N. & Feldmann, M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244–247 (1989). - DOI - PubMed
1. Elliott, M. J. et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNFα. Arthritis Rheum. 36, 1681–1690 (1993). - DOI - PubMed
1. Feldmann, M. & Maini, R. N. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9, 1245–1250 (2003). - DOI - PubMed
1. Sarzi-Puttini, P., Ceribelli, A., Marotto, D., Batticciotto, A. & Atzeni, F. Systemic rheumatic diseases: from biological agents to small molecules. Autoimmun. Rev. 18, 583–592 (2019). - DOI - PubMed
1. Simard, J. F. et al. Ten years with biologics: to whom do data on effectiveness and safety apply? Rheumatology 50, 204–213 (2010). - DOI - PubMed